Trafficking of GFP-tagged ΔF508-CFTR to the plasma membrane in a polarized epithelial cell line

American Journal of Physiology - Cell Physiology

Volumn 281, Issue 6 50-6, 2001, Pages

  Loffing Cueni, Dominique ^a   Loffing, J A N ^a   Shaw, Collin ^a   Taplin, Amilyn M ^a   Govindan, Malu ^a   Stanton, Caitlin R ^a   Stanton, Bruce A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Butyrate; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Dimethyl sulfoxide; Glycerol; Green fluorescent protein; Madin Darby canine kidney

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; BUTYRIC ACID; CHLORIDE; DIMETHYL SULFOXIDE; GLYCEROL; GREEN FLUORESCENT PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL POLARITY; CELL STRAIN; CELL TYPE; CHLORIDE CURRENT; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE;

ANIMALIA;

EID: 0035658385     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.2001.281.6.c1889     Document Type: Article

References (47)

1. Activation of ΔF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX
2. Activation of ΔF508 CFTR in an epithelial monolayer
3. Chemical chaperones correct the mutant phenotype of the ΔF508 cystic fibrosis transmembrane conductance regulator protein
4. Strategies for correcting the ΔF508 CFTR protein-folding defect
5. Cellular mechanisms of aquaporin trafficking
6. Protein trafficking and polarity in kidney epithelium: From cell biology to physiology
7. Functional activation of the cystic fibrosis trafficking mutant ΔF508-CFTR by overexpression
8. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
9. Generation and characterization of a ΔF508 cystic fibrosis mouse model
10. Functional cystic fibrosis transmembrane conductance regulator tagged with an epitope of the vesicular stomatis virus glycoprotein can be addressed to the apical domain of polarized cells
11. Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation
12. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
13. Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia
14. Pharmacological modulation of ion transport across wild-type and ΔF508 CFTR-expressing human bronchial epithelia
15. K
16. Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells
17. A ΔF508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo
18. Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties
19. Surface expression of the cystic fibrosis transmembrane conductance regulator mutant ΔF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature
20. The ΔF508 mutation shortens the biochemical half-life of plasma membrane CFTR in polarized epithelial cells
21. Genistein potentiates wild-type and ΔF508-CFTR channel activity
22. cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein
23. Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines
24. Partial restoration of cAMP-stimulated CFTR chloride channel activity in ΔF508 cells by deoxyspergualin
25. Aggresomes: A cellular response to misfolded proteins
26. Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland
27. Characterization of polyclonal and monoclonal antibodies to cystic fibrosis transmembrane conductance regulator
28. The cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR
29. The ΔF508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells
30. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations
31. Functional expression and apical localization of the cystic fibrosis transmembrane conductance regulator in MDCKI cells
32. - secretion in colonic epithelial cells expressing high levels of cystic fibrosis transmembrane conductance regulator
33. - secretion in epithelial cells
34. A PDZ-interacting domain in CFTR is an apical membrane polarization signal
35. Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in MadinDarby canine kidney cells
36. Butyrate increases apical membrane CFTR but reduces chloride secretion in MDCK cells
37. Confocal imaging of GFP labeled ion channels
38. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer
39. - channel is functional when retained in endoplasmic reticulum of mammalian cells
40. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
41. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing ΔF508-CFTR
42. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in ΔF508-homozygous cystic fibrosis patients: Partial restoration of nasal epithelial CFTR function
43. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation
44. Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium
45. - channels with altered pore properties
46. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function
47. Novel pharmacologic therapies for cystic fibrosis